Who
William Conkling
Director
Company insider
Files Form 4 as: Director, Idt; Chief Commercial Officer, Protara Therapeutics; Chief Executive Officer, Rafael Holdings; Director, Cyclo Therapeutics.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 15 Apr 2021
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | IDT IdtTelecom Carriers | SEC FORM 4 Code A | $38K673 at $55.75 | filing |
| 9 Jun 2026filed 11 Jun 2026 | IDT IdtTelecom Carriers | SEC FORM 4 Code A | $38K673 at $55.75 | filing |
| 2 Jun 2026filed 3 Jun 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $26K6,008 at $4.34 | filing |
| 2 Jun 2026filed 3 Jun 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code F | $26K6,008 at $4.34 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —158,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —158,000 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | TARA Protara Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | TARA Protara TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 25 Mar 2025filed 24 Apr 2025 | RFL Rafael Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,362 | filing |
| 25 Mar 2025filed 24 Apr 2025 | RFL Rafael Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,485 | filing |
| 25 Mar 2025filed 24 Apr 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code A | —27,454 | filing |
| 21 Mar 2025filed 25 Mar 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $29K14,814 at $1.93 | filing |
| 27 Feb 2025filed 3 Mar 2025 | Cyclo Therapeutics | SEC FORM 4 Code A | —27,654 at $0.00 | filing |
| 13 Jan 2025filed 15 Jan 2025 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code A | $117K60,000 at $1.95 | filing |
| 21 Dec 2024filed 23 Dec 2024 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $24K12,807 at $1.84 | filing |
| 15 Nov 2024filed 18 Nov 2024 | Cyclo Therapeutics | SEC FORM 4 Code A | —16,660 at $0.00 | filing |
| 25 Oct 2024filed 29 Oct 2024 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $6,3133,431 at $1.84 | filing |
| 21 Sep 2024filed 24 Sep 2024 | RFL Rafael HoldingsBiotechnology | SEC FORM 4 Code F | $22K12,696 at $1.73 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.